• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Monday, February 6, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home National

India Will Hopefully Get COVID-19 Vaccine Nod By Early January: AIIMS Director

by The Outlooker Web Desk
December 3, 2020
in National
0
Bharat Biotech Starts Phase III Trials For COVAXIN
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

No significant serious adverse effects have been seen in the 5 vaccine candidates. (Representational)

New Delhi:

AIIMS Director Dr Randeep Guleria pinned his hopes on the five COVID-19 vaccine candidates which are in advanced stages of clinical trial in India, stating they are logistically feasible for distribution in both urban and rural areas.

His assertion comes amid Pfizer-BioNTech’s anti-coronavirus vaccine getting emergency clearance in the UK, paving the way for mass vaccinations against the deadly novel coronavirus from as early as next week.

Dr Guleria expressed hope that by the end of this month or early next month, at least one of the five vaccines being locally-tested should get emergency use authorisation from the drug regulator to be administered to the public starting with priority groups.

According to sources, global pharma giant Pfizer had talks with the Indian government late August, but since then there has been no development.

During a briefing last month, NITI Aayog member (Health) Dr VK Paul, who also heads the National Expert Group on Vaccine Administration, said that sufficient doses of the Pfizer vaccine as required for the Indian population will not be available but the government is examining the possibilities and will work out a strategy (for its procurement and distribution) in case the vaccine gets regulatory approvals.

The requirement of an extreme low temperature of -70 deg C for storing the COVID-19 vaccine developed by Pfizer poses a big challenge for its delivery in a developing nation like India, especially in its smaller towns and rural areas where maintaining such cold chain facilities would be very difficult, Dr Guleria said.

“Five vaccine candidates are in advanced stages of clinical trial in India and no significant serious adverse effects have been seen so far. Also, they are logistically feasible for distribution in a large country like India, both in its urban and rural parts.”

Newsbeep

“Hopefully, by the end of this month or early next month, at least one of them should get emergency authorisation from the Indian drug regulator for its distribution among Indian population,” he said.

The five vaccines are under different phases of clinical trials in India with the Serum Institute of India conducting phase-3 trial of the Oxford-Astrazeneca COVID-19 vaccine, while the indigenously developed vaccine by Bharat Biotech in collaboration with ICMR has already started the phase-3 clinical trial.

Another indigenously-developed vaccine by Zydus Cadila has also completed phase -2 clinical trial in the country.

Dr Reddy’s Laboratories and the Russian Direct Investment Fund (RDIF) on Tuesday announced the start of adaptive phase 2 and 3 clinical trials for COVID-19 vaccine Sputnik V in India. Also, Biological E Ltd has started early phase 1 and 2 human trials of its COVID-19 vaccine candidate.

(If you like reading The Outlooker, please consider subscribing to us below. Subscriptions are free for first 500 subscribers.)

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Government Has No Ego, Says Agriculture Minister After 7-Hour Meet With Farmers

Government Has No Ego, Says Agriculture Minister After 7-Hour Meet With Farmers

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Rahul Gandhi Expresses Grief Over Loss Of Lives
National

Rahul Gandhi Expresses Grief Over Loss Of Lives

February 6, 2023
2 Soldiers Die As T-90 Tank Barrel Explodes During Firing Exercise In UP
National

In 2022-2023, Defence Expenditure Was 14.08% Of Expenses: Centre

February 6, 2023
“Who Is Shah Rukh Khan?” Assam’s Himanta Sarma When Asked About Pathaan
National

Teenage Pregnancy Ratio In State Quite Alarming, Says Assam Chief Minister Himanta Biswa Sarma

February 6, 2023
Congress Tripura manifesto promises old pension scheme, free 150 units of electricity
Politics

Congress Tripura manifesto promises old pension scheme, free 150 units of electricity

February 6, 2023

Connect with us

No Result
View All Result

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Rahul Gandhi Expresses Grief Over Loss Of Lives
  • In 2022-2023, Defence Expenditure Was 14.08% Of Expenses: Centre
  • Teenage Pregnancy Ratio In State Quite Alarming, Says Assam Chief Minister Himanta Biswa Sarma

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.